Piramal Pharma Solutions 在肯塔基州投资 $80m 以扩大无菌注射剂的生产能力。 Piramal Pharma Solutions invests $80m in Kentucky to expand sterile injectables production capacity.

Piramal Pharma Solutions正投资8 000万美元, 以扩大其在肯塔基州列克星敦的无菌注射设施。 Piramal Pharma Solutions is investing $80 million to expand its sterile injectables facility in Lexington, Kentucky. 到2027年,该项目将每年提高生产能力,从104批增加到240批以上,增加24 000平方英尺的空间和新机械。 The project will increase production capacity from 104 to over 240 batches annually by Q1 2027, adding 24,000 square feet of space and new machinery. 这一扩大旨在满足无菌注射器市场日益增长的需求,预计到2028年将超过200亿美元,并将创造40多个就业机会。 This expansion aims to meet the growing demand in the sterile injectables market, projected to exceed $20 billion by 2028, and will create over 40 jobs.